F. Caux

Inserm — France

Medicine · Health Sciences

45h-index8.1kcitations304works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune Bullous Skin Diseases(144), Coagulation, Bradykinin, Polyphosphates, and Angioedema(88), Urticaria and Related Conditions(87), PI3K/AKT/mTOR signaling in cancer(17), Platelet Disorders and Treatments(16)

Publications302 total

Le lupus pernio : intérêt de l’adalimumab à forte dose
La Revue de Médecine Interne·2025
003 Unveiling the phenotypic landscape of autoreactive Dsg3+ B Cells and CD83 pathway in pemphigus vulgaris: Towards new targets in a paradigm of autoimmunity
Journal of Investigative Dermatology·2025
Télangiectasies en nappes des zones de frottement et de la région génito-anale révélant une sclérodermie systémique cutanée diffuse
Annales de Dermatologie et de Vénéréologie - FMC·2025
Réduction du prurit chez un patient avec sclérodermie nodulaire traitée par dupilumab
Annales de Dermatologie et de Vénéréologie - FMC·2025
The importance of considering progression speed in systemic sclerosis—associated interstitial lung diseases: application of 2022 and 2024 clinical practice guidelines for progressive pulmonary fibrosis, a retrospective cohort study
Respiratory Research·2025· 2 citedOpen Access
Ustekinumab as a potential therapeutic agent in bullous pemphigoid: a biologic and clinical proof-of-concept study
British Journal of Dermatology·2025
Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two cases
Lara D. Veeken·2025· 2 cited
Evaluation of the efficacy and safety of dapsone alone or associated with topical corticosteroids for pemphigus foliaceus: a retrospective multicentre study
British Journal of Dermatology·2025
Author Correction: Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas
Nature Medicine·2025Open Access
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors
JAMA Dermatology·2025· 5 cited
Patterns de progression des PID associées à la sclérodermie systémique
Revue des Maladies Respiratoires Actualités·2025
Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece
JID Innovations·2024· 2 citedOpen Access
Patterns de progression des pneumopathies interstitielles diffuses associées à la sclérodermie systémique
La Revue de Médecine Interne·2024
Épidermolyse bulleuse acquise de l’enfant : série de 17 cas
Annales de Dermatologie et de Vénéréologie - FMC·2024
Délai de récidive des pemphigus traités par rituximab et corticothérapie locale
Annales de Dermatologie et de Vénéréologie - FMC·2024
Efficacité de l’éculizumab dans une dermatomyosite sévère à NXP2 avec vascularite digestive
Annales de Dermatologie et de Vénéréologie - FMC·2024
Classification of <i>PTEN</i> germline non-truncating variants: a new approach to interpretation
Journal of Medical Genetics·2024· 1 citedOpen Access
Clinical benefit from palbociclib, letrozole and goserelin combination therapy for sweat gland carcinoma with neuroendocrine differentiation (<scp>SCAND</scp>)
Journal of the European Academy of Dermatology and Venereology·2024· 1 cited
Activity of apremilast in a patient with severe pemphigus vulgaris: case report
Frontiers in Immunology·2024· 10 citedOpen Access
Editorial: Pemphigus and pemphigoid diseases: in memoriam Detlef Zillikens
Frontiers in Immunology·2024· 1 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

P. Joly(20), C. Prost‐Squarcioni(15), Michael Hertl(12), Philippe Bernard(11), M. Alexandre(11), Enno Schmidt(11), S. Oro(10), Dédée F. Murrell(10), Detlef Zillikens(10), P. Vabres(9), E. Delaporte(9), Luca Borradori(9), M. D’Incan(8), Branka Marinović(8), Claudio Feliciani(8), Giovanna Zambruno(8), B. Labeille(7), C. Paul(7), B. Sassolas(7), Jacques Bénichou(7)